You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MDASI-BT

Showing 1 - 25 of 250
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leptomeningeal Metastases Trial in United States (Involved-field Photon Radiation Therapy, Proton Craniospinal Irradiation

Active, not recruiting
  • Leptomeningeal Metastases
  • Involved-field Photon Radiation Therapy
  • +3 more
  • Basking Ridge, New Jersey
  • +7 more
Jul 22, 2022

6 Months Adjuvant Temozolomide vs No Adjuvant TMZ in Newly

Withdrawn
  • MGMT-Methylated Glioblastoma
  • Delay of TMZ
  • Standard of Care (SOC) Adjuvant TMZ (no intervention
  • (no location specified)
Aug 5, 2022

Astrocytoma, Oligodendroglioma, Adult, Glioma, Malignant Trial in Saint Louis (temporally-modulated pulsed radiotherapy (TMPRT))

Recruiting
  • Astrocytoma
  • +2 more
  • temporally-modulated pulsed radiotherapy (TMPRT)
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 19, 2023

Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,

Recruiting
  • Anaplastic Astrocytoma, IDH-Wildtype
  • +8 more
  • Quality-of-Life Assessment
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 8, 2022

IDH Family Wildtype, Recurrent Anaplastic Astrocytoma, Recurrent Glioblastoma Trial in Houston (Laser Interstitial Thermal

Terminated
Has Results
  • IDH Family Wildtype
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 14, 2022

Brain Tumor Trial in Houston (tepotinib, tepotinib plus osimertinib)

Not yet recruiting
  • Brain Tumor
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Recurrent Brain Tumor Trial in Houston (biological, other, radiation)

Active, not recruiting
  • Recurrent Brain Neoplasm
  • Bevacizumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 9, 2022

Metastatic Malignant Tumor in the Brain, Radiation Therapy Recipient Trial in Houston (behavioral, procedure, other)

Recruiting
  • Metastatic Malignant Neoplasm in the Brain
  • Radiation Therapy Recipient
  • Hand Function Test
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 14, 2022

Anxiety Trial run by the National Cancer Institute (NCI) (Pico G2 4K Headset with Applied VR software)

Recruiting
  • Anxiety
  • Pico G2 4K Headset with Applied VR software
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 30, 2023

Brain Metastases, Nonsmall Cell Lung Cancer Stage III Trial in Winston-Salem (MRI of the Brain, Blood draws, Quality of Life

Not yet recruiting
  • Brain Metastases
  • Nonsmall Cell Lung Cancer Stage III
  • MRI of the Brain
  • +2 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Cente
Jan 19, 2023

Breast Cancer Female, Leptomeningeal Metastases Trial in Charlottesville (HER2 BATs)

Terminated
  • Breast Cancer Female
  • Leptomeningeal Metastases
  • HER2 BATs
  • Charlottesville, Virginia
    University of Virginia
Dec 15, 2022

Metastatic Malignant Tumor in the Brain Trial (procedure, other, radiation)

Not yet recruiting
  • Metastatic Malignant Neoplasm in the Brain
  • Brain Surgery
  • +3 more
  • (no location specified)
Jun 24, 2022

Astrocytoma, IDH-Mutant, Grade 2, Astrocytoma, IDH-Mutant, Grade 3 Trial in United States (other, radiation, drug)

Active, not recruiting
  • Astrocytoma, IDH-Mutant, Grade 2
  • Astrocytoma, IDH-Mutant, Grade 3
  • Questionnaire Administration
  • +3 more
  • Phoenix, Arizona
  • +24 more
Dec 7, 2022

Brain Metastases, Radiosurgery Trial (Hippocampal-sparing, Stereotactic radiosurgery)

Not yet recruiting
  • Brain Metastases
  • Radiosurgery
  • Hippocampal-sparing
  • Stereotactic radiosurgery
  • (no location specified)
Feb 10, 2022

Gliosarcoma, MGMT-Unmethylated Glioblastoma Trial in United States (biological, device, other, radiation, drug)

Suspended
  • Gliosarcoma
  • MGMT-Unmethylated Glioblastoma
  • Ipilimumab
  • +6 more
  • Birmingham, Alabama
  • +285 more
Aug 24, 2022

HER2-positive Metastatic Breast Cancer, CNS Metastases Trial in Chicago, Boston (ATEZOLIZUMAB, PERTUZUMAB, TRASTUZUMAB)

Active, not recruiting
  • HER2-positive Metastatic Breast Cancer
  • Central Nervous System Metastases
  • Chicago, Illinois
  • +1 more
Mar 14, 2022

Glioblastoma, Brain Tumor, Glioma Trial in United States (Procedure: LITT, Hypo-Fractionated Radiation Therapy)

Recruiting
  • Glioblastoma
  • +3 more
  • Procedure: LITT
  • Hypo-Fractionated Radiation Therapy
  • Baltimore, Maryland
  • +3 more
Oct 10, 2022

IDH-mutant and IDH-wildtype Glioma Patients After

Recruiting
  • Glioma
  • RS-fMRI
  • Saint Louis, Missouri
    Washington University School of Medicine
Mar 8, 2022

Brain Connectivity After Tumor Resection

Recruiting
  • Brain Tumor
  • MRI
  • neuropsychological tests and qualitative assessment
  • Omaha, Nebraska
    UNMC/Nebraska Medicine
Sep 30, 2022

Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Tumor in the Brain, Stage IV Lung Cancer AJCC v8 Trial in Duarte

Not yet recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +2 more
  • Biospecimen Collection
  • +4 more
  • Duarte, California
    City of Hope Medical Center
May 1, 2023

Gliosarcoma, CNS Sarcoma Trial run by the NCI (Sunitinib, wGT3x-BT)

Terminated
Has Results
  • Gliosarcoma
  • Central Nervous System Sarcoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Mar 24, 2022

Glioblastoma Trial in Ann Arbor (Dose-Intensified Radiotherapy, Temozolomide, Adjuvant temozolomide)

Recruiting
  • Glioblastoma
  • Dose-Intensified Radiotherapy
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Dec 16, 2021

Glioma, Glioblastoma, Glioblastoma Multiforme Trial in Houston (VAL-083, Dianhydrogalactitol)

Active, not recruiting
  • Glioma
  • +4 more
  • VAL-083, Dianhydrogalactitol
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 23, 2022

NSCLC, Renal Cell Carcinoma, Breast Carcinoma Trial (single fraction stereotactic radiosurgery (SSRS), fractionated stereotactic

Not yet recruiting
  • NSCLC
  • +5 more
  • single fraction stereotactic radiosurgery (SSRS)
  • fractionated stereotactic radiosurgery (FSRS)
  • (no location specified)
Jan 18, 2023

Breast Cancer Trial in Boston (Atezolizumab, Stereotactic radiosurgery (SRS))

Active, not recruiting
  • Breast Cancer
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Aug 15, 2022